Who owns HAEMONETICS CORP MASS?

Tip: Access positions for across all investors

Analyze quarterly positions in Haemonetics Corp Mass with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Haemonetics Corp Mass stock

Who bought or sold HAEMONETICS CORP MASS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Linden Advisors 196M $204M 20% Dec 2025
 View chart
Wolverine Asset Management 68M $71M 20% Dec 2025
 View chart
BlackRock 60M $62M 768% Dec 2025
 View chart
Invesco 59M $61M 0% Dec 2025
 View chart
Franklin Resources 36M $38M -4% Dec 2025
 View chart
Zazove Associates 32M $30M -25% Sep 2025
 View chart
Wellesley Investment Advisors 29M $30B 2% Dec 2025
 View chart
Context Capital Management 23M $24M 90871% Dec 2025
 View chart
Advent Capital Management 18M $19M -39% Dec 2025
 View chart
State Street Corporation 15M $15M 0% Dec 2025
 View chart
CSS 13M $13M 100% Dec 2025
 View chart
Calamos Advisors 10M $10M -56% Dec 2025
 View chart
Lazard Asset Management 10M $104k 100% Dec 2025
 View chart
Wells Fargo & Company 9.9M $10M -53% Dec 2025
 View chart
Silverback Asset Management 8.4M $7.8M 100% Sep 2025
 View chart
Kim 7.5M $7.8M 0% Dec 2025
 View chart
Lombard Odier Asset Management 6.4M $6.7M 100% Dec 2025
 View chart
Wellington Management Company 6.3M $5.9M -5% Sep 2025
 View chart
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 5.6M $5.8M 0% Dec 2025
 View chart
Readystate Asset Management 5.0M $5.2M -50% Dec 2025
 View chart
FMR 4.9M $4.5M -5% Sep 2025
 View chart
SSI Investment Management 3.5M $3.6M -6% Dec 2025
 View chart
Income Research & Management 3.3M $3.4M 4% Dec 2025
 View chart
State of Wisconsin Investment Board 3.0M $3.1M 0% Dec 2025
 View chart
Leucadia National Corporation 1.8M $1.8M -21% Dec 2025
 View chart
New York State Common Retirement Fund 1.3M $1.4M -67% Dec 2025
 View chart
Shenkman Capital Management 1.3M $1.4B -89% Dec 2025
 View chart
Jpmorgan Chase & Co 1.3M $1.2M 100% Sep 2025
 View chart
Cutler Capital Management 1.2M $1.2M 0% Dec 2025
 View chart
Man Group 1.1M $1.1M -12% Dec 2025
 View chart
Universal- Beteiligungs- und Servicegesellschaft mbH 1.1M $1.1M -58% Dec 2025
 View chart
Goldman Sachs Group 1.0M $1.0M 100% Dec 2025
 View chart
Deutsche Bank Aktiengesellschaft 892k $924k 100% Dec 2025
 View chart
Kohlberg Kravis Roberts & Co 745k $691k 100% Sep 2025
 View chart
Bank of New York Mellon 650k $676k 30% Dec 2025
 View chart
Russell Investments 605k $631k 100% Dec 2025
 View chart
Zurcher Kantonalbank 600k $624k -47% Dec 2025
 View chart
Barclays 356k $370k 100% Dec 2025
 View chart
Royal Bank of Canada 185k $171k -82% Sep 2025
 View chart
Toronto-Dominion Bank 151k $139k -94% Sep 2025
 View chart
Cetera Investment Advisers 86k $89k 177% Dec 2025
 View chart
Wiley Bros.-aintree Capital 79k $82k 0% Dec 2025
 View chart
Rsm Us Wealth Management 33k $34k 18% Dec 2025
 View chart
Foresight Capital Management Advisors 27k $28k 100% Dec 2025
 View chart
Raymond James Financial 15k $16k 100% Dec 2025
 View chart
Insigneo Advisory Services 11k $11k -31% Dec 2025
 View chart
Brian McDonald 5.0k $5.2k 100% Dec 2025
 View chart
Candriam Luxembourg S.C.A. 200.00 $208k 100% Dec 2025
 View chart
Abn Amro Investment Solutions 200.00 $209k -100% Dec 2025
 View chart
Oddo Bhf Asset Management Sas 175.00 $182k 100% Dec 2025
 View chart
Advisor Group Holdings 5.00 $5.2k 0% Dec 2025
 View chart

Who sold out of Haemonetics Corp Mass?

Fund or Company Name Date Sold Shares Held Valued At
Camden Asset Management Sep 2025 69M $64B
Oaktree Capital Management Jun 2025 5.5M $5.4M
Two Sigma Investments Jun 2025 5.0M $5.0M
Bnp Paribas Arbitrage, Snc Sep 2025 3.8M $3.5M
Fore Capital Sep 2025 2.0M $1.9M
Dnca Finance Sep 2025 550k $512k
Laffer Investments Sep 2025 13k $1.2M
Wealth Enhancement Advisory Services Sep 2025 11k $10k